肌少症与感染住院长期风险的前瞻性关联:一项队列研究
基于英国生物银行243,097名参与者的前瞻性队列发现,基线肌少症(HR 1.62,95%CI 1.25-2.08)和可能肌少症(HR 1.40,95%CI 1.34-1.47)均与任何感染住院风险前瞻性相关,肌少症与胃肠道感染关联最强(HR 2.69)。
要点
- 基线肌少症和可能肌少症均与感染住院风险升高相关。
- 肌少症与胃肠道感染住院关联最强(HR 2.69)。
- 可能肌少症与肝脏感染住院相关(HR 1.76)。
核心结论
- 肌少症可能有助于识别感染住院高风险人群,支持对肌少症患者加强感染预防策略。
研究设计与样本
- 大型前瞻性队列研究,使用英国生物银行数据,基线评估握力和四肢瘦体重。
- 共纳入243,097名参与者(平均年龄55.64岁,女性52.7%),其中可能肌少症12,982人(5.3%),肌少症312人(0.1%)。
- 采用Cox回归分析评估肌少症与后续感染住院的关联。
主要发现
- 中位随访13.54年期间,26,769人因感染住院,其中可能肌少症2,357人(8.8%),肌少症60人(0.2%)。
- 完全调整模型中,基线肌少症与任何感染住院风险相关(HR 1.62;95%CI 1.25-2.08)。
- 基线可能肌少症与任何感染住院风险相关(HR 1.40;95%CI 1.34-1.47)。
- 肌少症与胃肠道感染住院强相关(HR 2.69;95%CI 1.27-5.68),可能肌少症与肝脏感染住院相关(HR 1.76;95%CI 1.22-2.54)。
- 可能肌少症组和肌少症组的平均感染住院次数显著高于非肌少症组(P < .001和P < .020),可能肌少症与确诊肌少症组间无显著差异(P = .684)。
临床怎么用
- 对肌少症或可能肌少症患者,应加强感染预防策略以降低感染住院风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The relationship between sarcopenia and the long-term risk of hospitalization for infectious diseases is unclear. This study aimed to evaluate this relationship using a large prospective Caucasian cohort from the UK Biobank. DESIGN: This is a large prospective cohort study. SETTING AND PARTICIPANTS: Using the UK Biobank data, participants were assessed for handgrip strength and appendicular lean mass at baseline and categorized into the non-sarcopenia, probable sarcopenia, and sarcopenia groups. A total of 243,097 participants (mean age, 55.64 years; 52.7% female) were enrolled in this study; 12,982 (5.3%) had probable sarcopenia and 312 (0.1%) had sarcopenia. METHODS: Cox regression analysis was used to evaluate associations between sarcopenia and subsequent hospitalizations for infections. The long-term risk of hospitalization for infections in different sarcopenia statuses was also examined. RESULTS: During the follow-up period (median, 13.54 years), 26,769 participants were hospitalized for infections, of whom 2357 (8.8%) had probable sarcopenia and 60 (0.2%) had sarcopenia. In the fully adjusted model, sarcopenia [hazard ratio (HR), 1.62; 95% confidence interval (CI), 1.25-2.08] and probable sarcopenia (HR, 1.40; 95% CI, 1.34-1.47) at baseline were prospectively associated with the risk of hospitalization for any infection. Sarcopenia was strongly associated with gastrointestinal infections (HR, 2.69; 95% CI, 1.27-5.68), whereas probable sarcopenia was associated with liver infections (HR, 1.76; 95% CI, 1.22-2.54). The average numbers of hospitalizations for infection were significantly higher in the probable sarcopenia and sarcopenia groups than in the non-sarcopenia group (P < .001 and P < .020, respectively). No significant difference was observed between the probable and confirmed sarcopenia groups (P = .684). CONCLUSIONS AND IMPLICATIONS: Sarcopenia may help identify people at risk of hospitalization for infections, supporting the strategies for enhancing infection prevention among individuals with sarcopenia.
引用
- Yu W, Wang W, Ye X, et al. Prospective Association Between Sarcopenia and Long-Term Risk of Hospitalization for Infection: A Cohort Study. J Am Med Dir Assoc. 2025. PMID: 40456275. doi:10.1016/j.jamda.2025.105702
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。